Aligned Genetics Inc (238120) — Cash Flow-to-Debt Ratio
Aligned Genetics Inc (238120) has a Cash Flow-to-Debt Ratio of -0.21x as of September 2025, meaning its operating cash flow of ₩-2.04 Billion could theoretically repay 0% of its total liabilities (₩9.61 Billion) in one year. Explore how much of Aligned Genetics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aligned Genetics Inc Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Aligned Genetics Inc across 10 annual periods. Also explore how large is Aligned Genetics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Aligned Genetics Inc (2015–2024)
Year-by-year debt coverage analysis for Aligned Genetics Inc. For market capitalisation and broader financial context, see Aligned Genetics Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | ₩3.07 Billion | ₩8.78 Billion | ▲ +17.9% |
| 2023 | 0.30x | ₩2.85 Billion | ₩9.62 Billion | ▲ +7.3% |
| 2022 | 0.28x | ₩2.22 Billion | ₩8.05 Billion | ▲ +1417.9% |
| 2021 | 0.02x | ₩135.97 Million | ₩7.48 Billion | ▲ +104.8% |
| 2020 | 0.01x | ₩35.67 Million | ₩4.02 Billion | ▼ -95.1% |
| 2019 | 0.18x | ₩659.29 Million | ₩3.65 Billion | ▲ +121.8% |
| 2018 | -0.83x | ₩-1.75 Billion | ₩2.11 Billion | ▼ -57.3% |
| 2017 | -0.53x | ₩-876.75 Million | ₩1.67 Billion | ▲ +22.6% |
| 2016 | -0.68x | ₩-1.14 Billion | ₩1.68 Billion | ▼ -53.8% |
| 2015 | -0.44x | ₩-351.72 Million | ₩796.04 Million | — |